Latest From MetaCure Inc.
The global market for minimally invasive weight loss devices is expected to grow to $290m by 2021, a CAGR of 16%, driven in large part by the rising obesity epidemic and associated Type 2 diabetes. Meddevicetracker expects that enhancements and innovations, particularly in the growing intragastric balloon market, and emerging technologies by smaller companies, will lead the growth in the overall weight loss devices market. In this feature, we'll take a closer look at the overall market and regional landscape and take a deep dive into the fastest-growing intragastric balloon segment, providing key insights from a bariatric surgeon on the pros and cons of these technologies.
Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.
A record-breaking attendance at 2010's meeting of the American Society for Metabolic and Bariatric Surgery marked the growing interest in new ways to address the issue of obesity. Currently, less than 1% of a potential US patient population of 15 million who might benefit from bariatric surgery actually undergo the procedure, and surgeons are scrambling to understand why and to identify new, less invasive approaches that might help them better penetrate this enormous patient pool.
A new implantable device from Beta-Stim Ltd. is designed to eradicate type 2 diabetes. The start-up's Balance System provides electrical stimulation of the duodenum during food intake to reduce blood glucose levels. This profile was originally published in the June 2010 issue of Medtech Insight.
- Implantable Devices
- Therapeutic Areas
- Metabolic Disorders
- North America
- Parent & Subsidiaries
- MetaCure Inc.
- Senior Management
- Shai Policker, VP, Bus. Dev.
- Contact Info
Phone: (845) 359-2143
30 Ramland Rd. South
P.O. Box 2044 Orangeburg, NY 10962
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.